Abstract
Calcitonin gene-related peptide (CGRP) has a well known hypotensive effect on blood pressure primarily due to dilatation of small resistance vessels. This microvascular vasodilator effect can also lead to potentiation of inflammatory oedema formation and cell accumulation in the cutaneous microvasculature when applied or released locally. Moreover, an involvement of CGRP in hyperalgesia accompanying the inflammatory processes has been confirmed. Adrenomedullin (AM) is a member of calcitonin peptide family first isolated from pheochromocytoma cells. It is primarily produced by non-neural cell types. AM acts on CGRP receptors and also activates AM1 receptors, which CGRP does not. Both are G protein-linked receptors consisting of the same calcitonin receptor-like receptor in association with a different receptor activity modifying proteins. In this chapter we compare the actions of AM and CGRP on the microcirculation, on inflammatory oedema formation/cell accumulation and hyperalgesia.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- Akt:
-
protein kinase B
- AM:
-
adrenomedullin
- CGRP:
-
calcitonin gene-related peptide
- CL:
-
calcitonin receptor-like receptor
- DRG:
-
dorsal root ganglion
- GDNF:
-
glia-derived neurotrophic factor
- GSK3β:
-
glycogen synthase kinase 3 beta
- IB4:
-
isolectin B4
- IFNγ:
-
interferon gamma
- IL-1β:
-
interleukin 1 beta
- IL-6:
-
interleukin 6
- LI:
-
lamina I of the dorsal horn
- LIIi:
-
inner lamina II of the dorsal horn
- LIIo:
-
outer lamina II of the dorsal horn
- LPS:
-
lipopolysaccharide
- MPO:
-
myeloperoxidase
- NGF:
-
nerve growth factor
- NK1:
-
neurokinin 1 receptor
- NKA:
-
neurokinin A
- NKB:
-
neurokinin B
- NO:
-
nitric oxide
- PI3K:
-
phosphoinositide 3-kinase
- RAMP:
-
receptor activity modifying peptide
- SP:
-
substance P
- TNFα:
-
tumor necrosis factor alpha
- TRPV1:
-
transient receptor potential vanilloid 1
- VIP:
-
vasoactive intestinal peptide
References
Bennett G, al-Rashed S, Hoult JR et al (1998) Nerve growth factor induced hyperalgesia in the rat hind paw is dependent on circulating neutrophils. Pain 77:315–322
Brain SD, Grant AD (2004) Vascular actions of calcitonin gene-related peptide and adrenomedullin. Physiol Rev 84:903–934
Brain SD, Williams TJ (1988) Substance P regulates the vasodilator activity of calcitonin gene-related peptide. Nature 335:73–75
Brain SD, Williams TJ, Tippins JR et al (1985) Calcitonin gene-related peptide is a potent vasodilator. Nature 313:54–56
Buckley TL, Brain SD, Collins PD et al (1991a) Inflammatory edema induced by interactions between IL-1 and the neuropeptide calcitonin gene-related peptide. J Immunol 146:3424–3430
Buckley TL, Brain SD, Rampart M et al (1991b) Time-dependent synergistic interactions between the vasodilator neuropeptide, calcitonin gene-related peptide (CGRP) and mediators of inflammation. Br J Pharmacol 103:1515–1519
Bühlmann N, Leuthäuser K, Muff R et al (1999) A receptor activity modifying protein (RAMP)2-dependent adrenomedullin receptor is a calcitonin gene-related peptide receptor when coexpressed with human RAMP1. Endocrinology 140:2883–2890
Bulling DG, Kelly D, Bond S et al (2001) Adjuvant-induced joint inflammation causes very rapid transcription of beta-preprotachykinin and alpha-CGRP genes in innervating sensory ganglia. J Neurochem 77:372–382
Caron KM, Smithies O (2001) Extreme hydrops fetalis and cardiovascular abnormalities in mice lacking a functional Adrenomedullin gene. Proc Natl Acad Sci U S A 98:615–619
Chiba T, Yamaguchi A, Yamatani T et al (1989) Calcitonin gene-related peptide receptor antagonist human CGRP-(8-37). Am J Physiol 256:E331–E335
Chu DQ, Choy M, Foster P et al (2000) A comparative study of the ability of calcitonin gene-related peptide and adrenomedullin(13–52) to modulate microvascular but not thermal hyperalgesia responses. Br J Pharmacol 130:1589–1596
Chu DQ, Legon S, Smith DM et al (2001) The calcitonin gene-related peptide (CGRP) antagonist CGRP(8–37) blocks vasodilatation in inflamed rat skin: involvement of adrenomedullin in addition to CGRP. Neurosci Lett 310:169–172
Cridland RA, Henry JL (1988) Effects of intrathecal administration of neuropeptides on a spinal nociceptive reflex in the rat: VIP, galanin, CGRP, TRH, somatostatin and angiotensin II. Neuropeptides 11:23–32
Dinarello CA (1994) The interleukin-1 family: 10 years of discovery. FASEB J 8:1314–1325
DiPette DJ, Wimalawansa SJ (1995) Calcium regulating hormones and cardiovascular function. In: Cross JI, Aveoli LV (eds) Cardiovascular actions of calcitropic hormones. CRC, Baltimore
Edvinsson L, Fredholm BB, Hamel E et al (1985) Perivascular peptides relax cerebral arteries concomitant with stimulation of cyclic adenosine monophosphate accumulation or release of an endothelium-derived relaxing factor in the cat. Neurosci Lett 58:213–217
Eguchi S, Hirata Y, Kano H et al (1994) Specific receptors for adrenomedullin in cultured rat vascular smooth muscle cells. FEBS Lett 340:226–230
Escott KJ, Brain SD (1993) Effect of a calcitonin gene-related peptide antagonist (CGRP8–37) on skin vasodilatation and oedema induced by stimulation of the rat saphenous nerve. Br J Pharmacol 110:772–776
Garcia-Unzueta MT, Martínez-Taboada VM, Amado-Señarís JA, Rodríguez-Valverde V (2006) Plasma adrenomedullin levels in patients with polymyalgia rheumatica and giant cell arteritis. Clin Exp Rheumatol 24:S6–S9
Garry MG, Hargreaves KM (1992) Enhanced release of immunoreactive CGRP and substance P from spinal dorsal horn slices occurs during carrageenan inflammation. Brain Res 582:139–142
Grant AD, Tam CW, Lazar Z et al (2004) The calcitonin gene-related peptide (CGRP) receptor antagonist BIBN4096BS blocks CGRP and adrenomedullin vasoactive responses in the microvasculature. Br J Pharmacol 142:1091–1098
Hall JM, Siney L, Lippton H et al (1995) Interaction of human adrenomedullin 13–52 with calcitonin gene-related peptide receptors in the microvasculature of the rat and hamster. Br J Pharmacol 114:592–597
Hanesch U, Blecher F, Stiller RU et al (1995) The effect of a unilateral inflammation at the rat’s ankle joint on the expression of preprotachykinin-A mRNA and preprosomatostatin mRNA in dorsal root ganglion cells – a study using non-radioactive in situ hybridization. Brain Res 700:279–284
Hasbak P, Eskesen K, Lind H et al (2006) The vasorelaxant effect of adrenomedullin, proadrenomedullin N-terminal 20 peptide and amylin in human skin. Basic Clin Pharmacol Toxicol 99:162–167
Hayakawa H, Hirata Y, Kakoki M et al (1999) Role of nitric oxide-cGMP pathway in adrenomedullin-induced vasodilation in the rat. Hypertension 33:689–693
Hirata Y, Mitaka C, Sato K et al (1996) Increased circulating adrenomedullin, a novel vasodilatory peptide, in sepsis. J Clin Endocrinol Metab 81:1449–1453
Hobara N, Nakamura A, Ohtsuka A et al (2004) Distribution of adrenomedullin-containing perivascular nerves in the rat mesenteric artery. Peptides 25:589–599
Ichiki Y, Kitamura K, Kangawa K et al (1994) Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma. FEBS Lett 338:6–10
Iseri SO, Ersoy Y, Gedik N et al (2008) Protective role of adrenomedullin in burn-induced remote organ damage in the rat. Regul Pept 146:99–105
Islek I, Balat A, Cekmen M et al (2003) Adrenomedullin and total nitrite levels in children with Henoch-Schönlein purpura. Pediatr Nephrol 18:1132–1137
Itoh T, Obata H, Murakami S et al (2007) Adrenomedullin ameliorates lipopolysaccharide-induced acute lung injury in rats. Am J Physiol Lung Cell Mol Physiol 293:L446–L452
Jancsó N, Jancsó-Gábor A, Szolcsányi J (1967) Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin. Br J Pharmacol Chemother 31:138–151
Kamoi H, Kanazawa H, Hirata K et al (1995) Adrenomedullin inhibits the secretion of cytokine-induced neutrophil chemoattractant, a member of the interleukin-8 family, from rat alveolar macrophages. Biochem Biophys Res Commun 211:1031–1035
Kinoshita H, Fujimoto S, Kitamura K et al (2000) Increased plasma levels of mature adrenomedullin in chronic glomerulonephritis. Nephron 86:333–338
Kitamura K, Kangawa K, Kawamoto M et al (1993) Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 192:553–560
Kubo A, Minamino N, Isumi Y et al (1998a) Adrenomedullin production is correlated with differentiation in human leukemia cell lines and peripheral blood monocytes. FEBS Lett 426:233–237
Kubo A, Minamino N, Isumi Y et al (1998b) Production of adrenomedullin in macrophage cell line and peritoneal macrophage. J Biol Chem 273:16730–16738
Kubo A, Iwano M, Minamino N et al (1998c) Measurement of plasma and urinary adrenomedullin in patients with IgA nephropathy. Nephron 78:389–394
Lang MG, Paternò R, Faraci FM et al (1997) Mechanisms of adrenomedullin-induced dilatation of cerebral arterioles. Stroke 28:181–185
Ley K, Laudanna C, Cybulsky MI et al (2007) Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 7:678–689
Ma W, Chabot JG, Quirion R (2006) A role for adrenomedullin as a pain-related peptide in the rat. Proc Natl Acad Sci U S A 103:16027–16032
Mak A, Cheung BM, Mok CC, Leung R, Lau CS (2006) Adrenomedullin–a potential disease activity marker and suppressor of nephritis activity in systemic lupus erythematosus. Rheumatology (Oxford) 45:1266–1272
McLatchie LM, Fraser NJ, Main MJ et al (1998) RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393:333–339
Mok MY, Cheung BM, Lo Y, Leung RY, Wong WS, Lau CS (2007) Elevated plasma adrenomedullin and vascular manifestations in patients with systemic sclerosis. J Rheumatol 34:2224–2229
Nagaya N, Satoh T, Nishikimi T et al (2000) Hemodynamic, renal, and hormonal effects of adrenomedullin infusion in patients with congestive heart failure. Circulation 101:498–503
Nakamura K, Toda H, Terasako K et al (1995) Vasodilative effect of adrenomedullin in isolated arteries of the dog. Jpn J Pharmacol 67:259–262
Nakayama M, Takahashi K, Murakami O et al (1999) Adrenomedullin in monocytes and macrophages: possible involvement of macrophage-derived adrenomedullin in atherogenesis. Clin Sci (Lond) 97:247–251
Nelson MT, Huang Y, Brayden JE et al (1990) Arterial dilations in response to calcitonin gene-related peptide involve activation of K+ channels. Nature 344:770–773
Nishimatsu H, Suzuki E, Nagata D et al (2001) Adrenomedullin induces endothelium-dependent vasorelaxation via the phosphatidylinositol 3-kinase/Akt-dependent pathway in rat aorta. Circ Res 89:63–70
Niu P, Shindo T, Iwata H et al (2004) Protective effects of endogenous adrenomedullin on cardiac hypertrophy, fibrosis, and renal damage. Circulation 109:1789–1794
Nomura I, Abe J, Noma S et al (2005) Adrenomedullin is highly expressed in blood monocytes associated with acute Kawasaki disease: a microarray gene expression study. Pediatr Res 57:49–55
Nossaman BD, Feng CJ, Kaye AD et al (1996) Pulmonary vasodilator responses to adrenomedullin are reduced by NOS inhibitors in rats but not in cats. Am J Physiol 270:L782–L789
Nuki C, Kawasaki H, Kitamura K et al (1993) Vasodilator effect of adrenomedullin and calcitonin gene-related peptide receptors in rat mesenteric vascular beds. Biochem Biophys Res Commun 196:245–251
Ohtori S, Takahashi K, Chiba T et al (2001) Phenotypic inflammation switch in rats shown by calcitonin gene-related peptide immunoreactive dorsal root ganglion neurons innervating the lumbar facet joints. Spine 26:1009–1013
Okumura H, Nagaya N, Itoh T et al (2004) Adrenomedullin infusion attenuates myocardial ischemia/reperfusion injury through the phosphatidylinositol 3-kinase/Akt-dependent pathway. Circulation 109:242–248
Petersen KA, Nilsson E, Olesen J et al (2005) Presence and function of the calcitonin gene-related peptide receptor on rat pial arteries investigated in vitro and in vivo. Cephalalgia 25:424–432
Poyner D (1995) Pharmacology of receptors for calcitonin gene-related peptide and amylin. Trends Pharmacol Sci 16:424–428
Quirion R, Van Rossum D, Dumont Y et al (1992) Characterization of CGRP1 and CGRP2 receptor subtypes. Ann N Y Acad Sci 657:88–105
Raddino R, Pelà G, Manca C et al (1997) Mechanism of action of human calcitonin gene-related peptide in rabbit heart and in human mammary arteries. J Cardiovasc Pharmacol 29:463–470
Saito Y, Nakao K, Nishimura K et al (1987) Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: beneficial effects on left ventricular function. Circulation 76:115–124
Saito Y, Nakagawa C, Uchida H et al (2001) Adrenomedullin suppresses fMLP-induced upregulation of CD11b of human neutrophils. Inflammation 25:197–201
Sampson AP (2000) The role of eosinophils and neutrophils in inflammation. Clin Exp Allergy 30(Suppl 1):22–27
Satoh M, Perkins E, Kimura H et al (2002) Posttreatment with adenovirus-mediated gene transfer of calcitonin gene-related peptide to reverse cerebral vasospasm in dogs. J Neurosurg 97:136–142
Schindler M, Doods HN (2002) Binding properties of the novel, non-peptide CGRP receptor antagonist radioligand, [(3)H]BIBN4096BS. Eur J Pharmacol 442:187–193
Sexton PM, Albiston A, Morfis M et al (2001) Receptor activity modifying proteins. Cell Signal 13:73–83
Shindo T, Kurihara Y, Nishimatsu H et al (2001) Vascular abnormalities and elevated blood pressure in mice lacking adrenomedullin gene. Circulation 104:1964–1971
Snider WD, McMahon SB (1998) Tackling pain at the source: new ideas about nociceptors. Neuron 20:629–632
Sugo S, Minamino N, Kangawa K et al (1994a) Endothelial cells actively synthesize and secrete adrenomedullin. Biochem Biophys Res Commun 201:1160–1166
Sugo S, Minamino N, Shoji H et al (1994b) Production and secretion of adrenomedullin from vascular smooth muscle cells: augmented production by tumor necrosis factor-alpha. Biochem Biophys Res Commun 203:719–726
Sun RQ, Tu YJ, Lawand NB et al (2004) Calcitonin gene-related peptide receptor activation produces PKA- and PKC-dependent mechanical hyperalgesia and central sensitization. J Neurophysiol 92:2859–2866
Szolcsanyi J (1982) Capsaicin type pungent agents producing pyrexia. In: Milton AS (ed) Handbook of experimental pharmacology. Springer, Berlin
Tam CW, Husmann K, Clark NC et al (2006) Enhanced vascular responses to adrenomedullin in mice overexpressing receptor-activity-modifying protein 2. Circ Res 98:262–270
Tomoda Y, Isumi Y, Katafuchi T et al (2001) Regulation of adrenomedullin secretion from cultured cells. Peptides 22:1783–1794
Van der Schueren BJ, Rogiers A, Vanmolkot FH et al (2008) Calcitonin gene-related peptide8-37 antagonizes capsaicin-induced vasodilation in the skin: evaluation of a human in vivo pharmacodynamic model. J Pharmacol Exp Ther 325:248–255
Watanabe K, Takayasu M, Noda A et al (2001) Adrenomedullin reduces ischemic brain injury after transient middle cerebral artery occlusion in rats. Acta Neurochir (Wien) 143:1157–1161
Williams TJ, Peck MJ (1977) Role of prostaglandin-mediated vasodilatation in inflammation. Nature 270:530–532
Wimalawansa SJ (1996) Calcitonin gene-related peptide and its receptors: molecular genetics, physiology, pathophysiology, and therapeutic potentials. Endocr Rev 17:533–585
Zaks-Zilberman M, Salkowski CA, Elsasser T et al (1998) Induction of adrenomedullin mRNA and protein by lipopolysaccharide and paclitaxel (Taxol) in murine macrophages. Infect Immun 66:4669–4675
Acknowledgments
We thank the British Heart Foundation and the British Biotechnology Science Research Council (BBSRC) for funding. LL is supported by an IMB capacity building award.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media B.V
About this chapter
Cite this chapter
Pozsgai, G., Liang, L., Brain, S.D. (2010). Vascular Actions of CGRP and Adrenomedullin: Mechanisms and Potential Contribution to Inflammation in the Cutaneous Microvasculature. In: Hay, D., Dickerson, I. (eds) The calcitonin gene-related peptide family. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-2909-6_8
Download citation
DOI: https://doi.org/10.1007/978-90-481-2909-6_8
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-2908-9
Online ISBN: 978-90-481-2909-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)